Cambridge Investment Research Advisors’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Hold |
10,500
| – | – | ﹤0.01% | 3599 |
|
|
2025
Q1 | $10K | Hold |
10,500
| – | – | ﹤0.01% | 3483 |
|
|
2024
Q4 | $10K | Hold |
10,500
| – | – | ﹤0.01% | 3444 |
|
|
2024
Q3 | $13K | Hold |
10,500
| – | – | ﹤0.01% | 3385 |
|
|
2024
Q2 | $14K | Sell |
10,500
-500
| -5% | -$667 | ﹤0.01% | 3279 |
|
|
2024
Q1 | $17K | Buy |
11,000
+500
| +5% | +$773 | ﹤0.01% | 3269 |
|
|
2023
Q4 | $12K | Sell |
10,500
-6,000
| -36% | -$6.86K | ﹤0.01% | 3160 |
|
|
2023
Q3 | $14K | Sell |
16,500
-1,000
| -6% | -$848 | ﹤0.01% | 3100 |
|
|
2023
Q2 | $20K | Hold |
17,500
| – | – | ﹤0.01% | 3124 |
|
|
2023
Q1 | $18K | Hold |
17,500
| – | – | ﹤0.01% | 3109 |
|
|
2022
Q4 | $20K | Sell |
17,500
-8,500
| -33% | -$9.71K | ﹤0.01% | 3042 |
|
|
2022
Q3 | $29K | Hold |
26,000
| – | – | ﹤0.01% | 2981 |
|
|
2022
Q2 | $38K | Hold |
26,000
| – | – | ﹤0.01% | 2963 |
|
|
2022
Q1 | $60K | Sell |
26,000
-5,900
| -18% | -$13.6K | ﹤0.01% | 3065 |
|
|
2021
Q4 | $88K | Sell |
31,900
-10,950
| -26% | -$30.2K | ﹤0.01% | 3047 |
|
|
2021
Q3 | $257K | Buy |
42,850
+12,650
| +42% | +$75.9K | ﹤0.01% | 2589 |
|
|
2021
Q2 | $147K | Sell |
30,200
-1,200
| -4% | -$5.84K | ﹤0.01% | 2901 |
|
|
2021
Q1 | $78K | Buy |
31,400
+21,400
| +214% | +$53.2K | ﹤0.01% | 2785 |
|
|
2020
Q4 | $27K | Buy |
+10,000
| New | +$27K | ﹤0.01% | 2674 |
|